FDA Drug Directory Dangerously Incomplete: Report

Law360, New York (August 15, 2006, 12:00 AM EDT) -- A report has found that the Food and Drug Administration’s national drug directory is sorely incomplete because it omits thousands of drugs while including thousands of others that have long gone off the market.

“The failure of firms to list drug products with FDA limits the usefulness of the directory to all who rely on it for timely information about prescription drugs on the market,” said the report, issued this month from the Department of Health and Human Service’s Office of the Inspector General.

The FDA’s...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.